Trial drug overcomes resistant chronic myeloid leukemiaOmacetaxine battles genetic mutation that negates existing therapy Adjuvant therapy has feverish results in real-world careFebrile neutropenia observed at higher than expected rate Chemo- trastuzumab combo ups survival FPs should take lead in reducing breast cancer risk Online tool helps family doctors screen women to detect higher-risk patients Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Rethinking breast cancer Statins benefit leukemia patients Clinical trials needed to pinpoint ideal candidates Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen Study OKs dose boost for estrogen receptor antagonist Wait times for diagnosis exceed accepted targets Groups collaborate on chronic disease prevention $15.5M invested in chronic disease prevention by Canadian Partnership Against Cancer Nova Scotia, Newfoundland form breast cancer screening partnership First Previous 66 67 68 69 70 Next Last
